Am J Dermatopathol

1. TREPANOWSKI N, Shah P, Sriharan A, Simmons B, et al
   Progressive Nonhealing Lower Extremity Ulcers: Challenge.
   Am J Dermatopathol. 2024;46:e61-e62.
   

   >> Share

   
   
2. FAWZY MM, Abdelraouf SM, Korany MM
   Multiple Erythematous Papules and Nodules on a Scalp: Challenge.
   Am J Dermatopathol. 2024;46:e59-e60.
   

   >> Share

   
   
3. SHAKER N, Phelps R, Niedt G, Sangueza OP, et al
   Insights Into a Rare Spindle Cell Neoplasm of the Cheek and Its Significant Prognostic Factors: Challenge.
   Am J Dermatopathol. 2024;46:e57-e58.
   

   >> Share

   
   
4. TREPANOWSKI N, Shah P, Sriharan A, Simmons B, et al
   Progressive Nonhealing Lower Extremity Ulcers: Answer.
   Am J Dermatopathol. 2024;46:546-547.
   

   >> Share

   
   
5. FAWZY MM, Abdelraouf SM, Korany MM
   Multiple Erythematous Papules and Nodules on a Scalp: Answer.
   Am J Dermatopathol. 2024;46:545.
   

   >> Share

   
   
6. SHAKER N, Phelps R, Niedt G, Sangueza OP, et al
   Solitary Fibrous Tumor of the Cheek: Navigating Pathology and Advanced Multivariate Risk Stratification Assessment Models: A Clinicopathologic Challenge.
   Am J Dermatopathol. 2024;46:542-544.
   

   >> Share

   
   
7. EHSAN E, Wei EX, Georgesen C
   Histopathologic Features of Drug Reaction With Eosinophilia and Systemic Symptoms.
   Am J Dermatopathol. 2024;46:499-504.
   

   >> Share

   
   
8. ENGEL CE, Fagan KK, Dorsey SB, Grider DJ, et al
   An Unexpected Post-Egg-Free Influenza Vaccine Granulomatous Reaction.
   Am J Dermatopathol. 2024;46:e63-e65.
   

   >> Share

   
   
9. MENDEZ-FLORES S, Perales-Gonzalez A, Saeb-Lima M
   Sweet Syndrome as a Herpetiform Mimic: A Diagnostic Challenge.
   Am J Dermatopathol. 2024;46:512-513.
   

   >> Share

   
   
10. HIRAKI T, Oishi T, Yoshikawa S, Honma K, et al
    Loss of p16 Immunoexpression and Deletions of CDKN2A in the Progression of Extramammary Paget Disease: An Immunohistochemical and Genetic Study of 24 Invasive/Metastatic Cases.
    Am J Dermatopathol. 2024;46:492-498.
    

    >> Share

    
    

    
    Am J Ophthalmol

11. WYLEGALA A, Pajak J, Wylegala E
    Bilateral Corneal and Conjunctival Melanosis.
    Am J Ophthalmol. 2024 May 17:S0002-9394(24)00206.
    

    >> Share

    
    

    
    BMC Cancer

12. TANG H, Zhang W, Shen H, Tang H, et al
    A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trial.
    BMC Cancer. 2024;24:859.
    

    >> Share

    
    
13. SOHRABEI S, Moghaddasi H, Hosseini A, Ehsanzadeh SJ, et al
    Investigating the effects of artificial intelligence on the personalization of breast cancer management: a systematic study.
    BMC Cancer. 2024;24:852.
    

    >> Share

    
    
14. CHRISTINE D, Christian SF, Ricarda K, Christine K, et al
    Risk factors for residual fibroglandular breast tissue following a mastectomy - an overview and retrospective cohort study.
    BMC Cancer. 2024;24:856.
    

    >> Share

    
    
15. JIA L, Peng J, Sun N, Chen H, et al
    Effect of PR status on the prognosis of advanced ER-high HER2-negative breast cancer patients receiving CDK4/6 inhibitor combined with endocrine as first-line therapy.
    BMC Cancer. 2024;24:850.
    

    >> Share

    
    
16. YIN W, Li R, Zhang Z, Wang Y, et al
    Causal association between skin cancer and immune cells: mendelian randomization (MR) study.
    BMC Cancer. 2024;24:849.
    

    >> Share

    
    
17. DAMTIE Z, Cherie N, Agidew MM
    Breast cancer preventive practices and associated factors among reproductive age women in Wadila District, North East Ethiopia: community based cross-sectional study.
    BMC Cancer. 2024;24:843.
    

    >> Share

    
    

    
    Br J Dermatol

18. 
    New British Skin Foundation/Skin Health Alliance Psychodermatology Research Award now available.
    Br J Dermatol. 2024;191:309.
    

    >> Share

    
    
19. BATTISTELLA M
    Paediatric lymphomatoid papulosis: a benign clonal T-cell disorder that is a harbinger of haematological malignancy.
    Br J Dermatol. 2024;191:158-159.
    

    >> Share

    
    
20. DOOLAN BJ, Thomas BR
    Bursting the bubble on diagnostics: artificial intelligence in autoimmune bullous disease.
    Br J Dermatol. 2024;191:160-161.
    

    >> Share

    
    
21. ANDRADE LF, Haq Z, Abdi P, Diaz MJ, et al
    Impact of pruritus on patient fatigue: a cross-sectional study.
    Br J Dermatol. 2024;191:292-293.
    

    >> Share

    
    
22. REICH A
    Nemolizumab: a new key player in the treatment of prurigo nodularis.
    Br J Dermatol. 2024;191:154-155.
    

    >> Share

    
    
23. THEIN D, Maul JT, Schmid-Grendelmeier P, Thyssen JP, et al
    Prevalence of ichthyoses in Denmark: a nationwide registry-based study.
    Br J Dermatol. 2024;191:305-306.
    

    >> Share

    
    
24. SAMUELOV L
    Dystrophic epidermolysis bullosa: from disease biology to biologic therapy.
    Br J Dermatol. 2024;191:159-160.
    

    >> Share

    
    
25. GAMBICHLER T, Razeghpour F, Sorescu E, Stucker M, et al
    High intratumoral 5-hydroxymethylcytosine levels protect against disease relapse in patients with atypical fibroxanthoma and pleomorphic dermal sarcoma.
    Br J Dermatol. 2024;191:295-296.
    

    >> Share

    
    
26. GUPTA V, Taneja N, Sati HC, Sreenivas V, et al
    'Substantial clinical benefit' and 'substantial clinical worsening' cutoff of Vitiligo Impact Scale (VIS)-22 change scores.
    Br J Dermatol. 2024;191:307-308.
    

    >> Share

    
    
27. GRATTAN CEH, Kocaturk E
    How relevant are eosinophils to chronic spontaneous urticaria? No evidence of clinical benefit from eosinophil depletion with benralizumab.
    Br J Dermatol. 2024;191:153-154.
    

    >> Share

    
    
28. SARKOVICS K, Kolodney JA, Kolodney MS
    Programmed death receptor-1 and programmed death ligand-1 checkpoint inhibition-associated bullous pemphigoid: a propensity-matched retrospective cohort study.
    Br J Dermatol. 2024;191:299-300.
    

    >> Share

    
    
29. YOKOZEKI H, Murota H, Matsumura T, Komazaki H, et al
    Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: results from a randomized double-blind placebo-controlled phase II/III clinical study in patients aged >/= 13 years.
    Br J Dermatol. 2024;191:200-208.
    

    >> Share

    
    
30. BRAZZELLI V, Michelerio A
    Use of a large patient database to analyse disease burden and treatment patterns among patients with vitiligo.
    Br J Dermatol. 2024;191:156-157.
    

    >> Share

    
    
31. MCCARTHY RL, Schwartz J, Oldham J, Bodemer C, et al
    A cross-sectional study of erythromelalgia in patients with pachyonychia congenita.
    Br J Dermatol. 2024;191:300-302.
    

    >> Share

    
    
32. CAPURRO N, Pastore VP, Touijer L, Odone F, et al
    A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.
    Br J Dermatol. 2024;191:261-266.
    

    >> Share

    
    
33. ELEFTHERIADOU V, Delattre C, Chetty-Mhlanga S, Lee C, et al
    Burden of disease and treatment patterns in patients with vitiligo: findings from a national longitudinal retrospective study in the UK.
    Br J Dermatol. 2024;191:216-224.
    

    >> Share

    
    
34. LAIMER M
    Nonsense variant readthrough therapy for epidermolysis bullosa.
    Br J Dermatol. 2024;191:161-162.
    

    >> Share

    
    
35. CAMPBELL F, Laws P
    Managing risk of liver fibrosis in patients with psoriasis being considered for methotrexate.
    Br J Dermatol. 2024;191:163.
    

    >> Share

    
    
36. ALTRICHTER S, Gimenez-Arnau AM, Bernstein JA, Metz M, et al
    Benralizumab does not elicit therapeutic effect in patients with chronic spontaneous urticaria: results from the phase IIb multinational randomized double-blind placebo-controlled ARROYO trial.
    Br J Dermatol. 2024;191:187-199.
    

    >> Share

    
    
37. WOODLEY DT, Hao M, Kwong A, Levian B, et al
    Intravenous gentamicin therapy induces functional type VII collagen in patients with recessive dystrophic epidermolysis bullosa: an open-label clinical trial.
    Br J Dermatol. 2024;191:267-274.
    

    >> Share

    
    
38. HOWELLS L
    Patient-Reported Impact of Dermatological Diseases (PRIDD) is a new patient-reported outcome measure for dermatology: why is it needed?
    Br J Dermatol. 2024;191:e4.
    

    >> Share

    
    
39. XU Y, Guo L, Wu S, Zhang T, et al
    Causal effect of elevated body mass index on hidradenitis suppurativa: a two-sample Mendelian randomization study.
    Br J Dermatol. 2024;191:290-292.
    

    >> Share

    
    

    
    Cancer

40. NIERENGARTEN MB
    Inequities in breast cancer from prevention through supportive care.
    Cancer. 2024;130:2570.
    

    >> Share

    
    
41. MILLER DM, Shalhout SZ, Wright KM, Miller MA, et al
    The prognostic value of the Merkel cell polyomavirus serum antibody test: A dual institutional observational study.
    Cancer. 2024;130:2670-2682.
    

    >> Share

    
    

    
    Cancer Res

42. XIA J, Zhang L, Peng X, Tu J, et al
    IL1R2 blockade alleviates immunosuppression and potentiates anti-PD-1 efficacy in triple-negative breast cancer.
    Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-23-3429.
    

    >> Share

    
    

    
    Clin Exp Dermatol

43. GOKTAS P, Gulseren D, Tobin AM
    Large Language and Vision Assistant in dermatology: a game changer or just hype?
    Clin Exp Dermatol. 2024;49:783-792.
    

    >> Share

    
    
44. KOBAYASHI Y, Nakamura Y, Tahara U, Nakamura K, et al
    Identification of a rare MET variant in three siblings with extramammary Paget disease.
    Clin Exp Dermatol. 2024;49:882-886.
    

    >> Share

    
    
45. KAUR A, Nixon R
    General dermatology and dermatology in primary healthcare.
    Clin Exp Dermatol. 2024;49:937-938.
    

    >> Share

    
    
46. PEARCE J, Al-Wahab Y, Rao A, Natkunarajah J, et al
    A case of periocular pyoderma gangrenosum successfully managed with the aid of hyperbaric oxygen therapy.
    Clin Exp Dermatol. 2024;49:926-929.
    

    >> Share

    
    
47. PARKIN D, Ling TC, Ayer J, Rhodes LE, et al
    'Omalizumab changed my life': a patient perspective on solar urticaria.
    Clin Exp Dermatol. 2024;49:935-936.
    

    >> Share

    
    
48. RYAN S, Kravvas G, Wilson JM, Bunker CB, et al
    Extensive calcinosis cutis complicating radiotherapy.
    Clin Exp Dermatol. 2024;49:918-920.
    

    >> Share

    
    
49. LAU CB, Smith GP
    Nailfold capillary abnormalities are associated with increased severity of Raynaud phenomenon among patients with systemic sclerosis: a pilot study.
    Clin Exp Dermatol. 2024;49:912-913.
    

    >> Share

    
    
50. MUNOZ CASTRO D, Albanell Fernandez C, Martin Hernandez JM, Silva Diaz E, et al
    An atypical nodule on the toe of a paediatric patient.
    Clin Exp Dermatol. 2024;49:901-903.
    

    >> Share

    
    
51. BURLANDO M, Salvi I, Parodi A, Cozzani EC, et al
    Paradoxical eruption exclusively located on the ear in patients with psoriasis treated with biologics: a case series.
    Clin Exp Dermatol. 2024;49:899-901.
    

    >> Share

    
    
52. AWAD A, Sharma P, Bhoyrul B
    Variants of female pattern hair loss in men.
    Clin Exp Dermatol. 2024;49:898-899.
    

    >> Share

    
    
53. LECOEUVRE H, Le Gall F, Le Naoures C, Vignon-Pennamen MD, et al
    Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndrome.
    Clin Exp Dermatol. 2024;49:825-833.
    

    >> Share

    
    
54. KIM YC, Woo B, Kim HN, Kim KE, et al
    Human papillomavirus detection rates in Bowen disease: correlation with pelvic and digital region involvement and specific p53 immunostaining patterns.
    Clin Exp Dermatol. 2024;49:848-858.
    

    >> Share

    
    
55. CHUO HE, Hsiao YC, Wu YH
    Should antituberculosis treatment be prescribed in erythema induratum? A case-control and incidence correlation study in Taiwan, 2001-2020.
    Clin Exp Dermatol. 2024;49:834-840.
    

    >> Share

    
    
56. CORNMAN HL, Kambala A, Nandi TR, Kwatra SG, et al
    No increased risk of postoperative adverse events in patients with hidradenitis suppurativa following a total joint replacement.
    Clin Exp Dermatol. 2024;49:879-881.
    

    >> Share

    
    
57. ZHAO C, Yu M, Cheng X, Li S, et al
    Associations between coagulation factors and livedoid vasculopathy and the efficacy and safety of rivaroxaban in patients with livedoid vasculopathy: a retrospective study.
    Clin Exp Dermatol. 2024;49:817-824.
    

    >> Share

    
    
58. CHEN CL, Wu CY, Chen YL, Chen CC, et al
    Association between vitiligo and risk of retinal detachment: a population-based cohort study in Taiwan.
    Clin Exp Dermatol. 2024;49:841-847.
    

    >> Share

    
    
59. TANG GT, Triwongwaranat D, Sinclair R, Joseph S, et al
    Treatment of moderate-to-severe alopecia areata in patients over the age of 65 years with baricitinib.
    Clin Exp Dermatol. 2024;49:875-878.
    

    >> Share

    
    
60. TOMALIN LE, Kolbinger F, Suprun M, Wharton KA Jr, et al
    Deep resolution of clinical, cellular and transcriptomic inflammatory markers of psoriasis over 52 weeks of interleukin-17A inhibition by secukinumab.
    Clin Exp Dermatol. 2024;49:801-809.
    

    >> Share

    
    

    
    Eur J Dermatol

61. MUSSI M, Zengarini C, Bardazzi F
    sQuiz your knowledge! When humans look like snakes: a curious python pattern on the hands and feet.
    Eur J Dermatol. 2024;34:351-352.
    

    >> Share

    
    
62. ZHOU Q, Zhang S, Li W
    sQuiz your knowledge! A keratotic nodule on a chronic burn scar.
    Eur J Dermatol. 2024;34:348-350.
    

    >> Share

    
    
63. NAGI P, Prakashey A, Sawatkar GU
    sQuiz your knowledge! Intractable nipple pruritus in a young female.
    Eur J Dermatol. 2024;34:347-348.
    

    >> Share

    
    
64. CEBOLLA-VERDUGO M, Gomez-Valcarcel JJ, Ruiz-Villaverde R
    sQUIZ your knowledge! Unravelling dermatological enigmas: a puzzling case of a cutaneous anomaly on the popliteal region of a 12-year-old boy.
    Eur J Dermatol. 2024;34:344-346.
    

    >> Share

    
    
65. REYNAUD V, Chircop I, Hacard F, Nicolas JF, et al
    Unusual dermatitis in response to a transcutaneous electrical nerve stimulation device.
    Eur J Dermatol. 2024;34:341-342.
    

    >> Share

    
    
66. DIAZ AR, Dege T, Chircop I, Reynaud V, et al
    Journal club: JAK inhibitors and safety.
    Eur J Dermatol. 2024;34:338-340.
    

    >> Share

    
    
67. YAMADA M, Kokubu H, Kato T, Fujimoto N, et al
    Portal vein stenosis and hepatic encephalopathy induced by eosinophilic granulomatosis with polyangiitis.
    Eur J Dermatol. 2024;34:335-337.
    

    >> Share

    
    
68. CHUNG JG, Morar N
    Scrofuloderma with extended lymphadenopathy: a rare presentation of tuberculosis mimicking hidradenitis suppurativa.
    Eur J Dermatol. 2024;34:334-335.
    

    >> Share

    
    
69. DENG X, Chen Y, Lei Z, Xu Y, et al
    Zosteriform cutaneous metastasis: a case report of ovarian neoplasms.
    Eur J Dermatol. 2024;34:332-334.
    

    >> Share

    
    
70. TAKEGAMI T, Nakajima Y, Okuno A, Cho R, et al
    Granulocyte colony-stimulating factor-producing cutaneous spindle cell squamous cell carcinoma: a case report.
    Eur J Dermatol. 2024;34:330-332.
    

    >> Share

    
    
71. HOU XY, Yao SL, Wang JY, Zhang J, et al
    Cutaneous Rosai-Dorfman-Destombes disease in a child: a case report and brief review.
    Eur J Dermatol. 2024;34:329-330.
    

    >> Share

    
    
72. KIMURA H, Hasegawa A, Kawai T, Ito M, et al
    A case of cutaneous adverse reaction to COVID-19 vaccine caused by polyethylene glycol.
    Eur J Dermatol. 2024;34:327-329.
    

    >> Share

    
    
73. IWATA JI, Sunohara R, Katsuno M
    A case of Sweet's syndrome successfully treated with minocycline.
    Eur J Dermatol. 2024;34:326-327.
    

    >> Share

    
    
74. NAKAJIMA H, Kamata M, Okada Y, Ito M, et al
    Erythema multiforme after initiating spesolimab in a patient with generalized pustular psoriasis with IL36RN mutation.
    Eur J Dermatol. 2024;34:324-325.
    

    >> Share

    
    
75. KAWANO A, Miyachi H, Ota M, Ikeda JI, et al
    Acquired tufted angioma with perinatal progression and complete spontaneous regression post-delivery: a case report and literature review on the expression of sex hormone receptors.
    Eur J Dermatol. 2024;34:322-323.
    

    >> Share

    
    
76. OU S, Rodriguez M, Baillard P, Kanitakis J, et al
    Mucinous carcinoma, a rare breast carcinoma diagnosed during dermatological examination.
    Eur J Dermatol. 2024;34:320-322.
    

    >> Share

    
    
77. GAMBICHLER T, Sandersfeld MH, Schaller J, Wiech T, et al
    Adult Henoch-Schonlein purpura complicated by IgA-nephritis in a patient with mantle cell lymphoma and Graves disease.
    Eur J Dermatol. 2024;34:318-320.
    

    >> Share

    
    
78. MIZAWA M, Makino T, Shimizu T
    Long-term observation of a piebald patient showing pigmentation within leukoderma.
    Eur J Dermatol. 2024;34:317-318.
    

    >> Share

    
    
79. YOON S, Lee SY, Lee GJ, Kim JS, et al
    Psoriasis and in situ or invasive non-melanoma skin cancer: a bidirectional Mendelian randomisation study.
    Eur J Dermatol. 2024;34:314-317.
    

    >> Share

    
    
80. OKAZAKI T, Fujimura T, Asano Y
    Multiple squamous cell carcinomas in situ in a patient with lung cancer treated with tepotinib.
    Eur J Dermatol. 2024;34:313-314.
    

    >> Share

    
    
81. FOTI C, Calianno G, Sbarra G, Pisani MC, et al
    Crusted scabies diagnosed in an atopic patient during treatment with upadacitinib.
    Eur J Dermatol. 2024;34:311-312.
    

    >> Share

    
    
82. CHEN S, Yang X, Lu Z
    X-linked hypohidrotic ectodermal dysplasia with a deletion in exon 2 of the EDA gene: a case report and literature review.
    Eur J Dermatol. 2024;34:310-311.
    

    >> Share

    
    
83. JIKIHARA N, Yokoi K, Matsumura Y, Ishitsuka Y, et al
    Successful treatment of aggressive metastatic sebaceous carcinoma with pembrolizumab.
    Eur J Dermatol. 2024;34:308-310.
    

    >> Share

    
    
84. BULTE E, Douxami M, Duvert-Lehembre S, Massip E, et al
    Bullous pemphigoid associated with cutaneous adnexal carcinoma.
    Eur J Dermatol. 2024;34:306-308.
    

    >> Share

    
    
85. UKAI Y, Yamamoto M, Ozaki Y, Akazawa A, et al
    Two cases of Birt-Hogg-Dube syndrome (Hornstein-Kinckenberg syndrome) with fibrofolliculoma and fibrous papules.
    Eur J Dermatol. 2024;34:305-306.
    

    >> Share

    
    
86. BARTHALON E, Dupire G, Calugareanu A, Said BB, et al
    Pamidronate-induced SDRIFE confirmed by skin testing without cross reactivity to zoledronate.
    Eur J Dermatol. 2024;34:304.
    

    >> Share

    
    
87. PANGASTUTI M, Dharmadji HP, Suwarsa O, Sutedja E, et al
    Acquired zinc deficiency mimicking infantile psoriasis in a premature infant with a developmental sex disorder.
    Eur J Dermatol. 2024;34:302-303.
    

    >> Share

    
    
88. MOCHIZUKI R, Nakatani S, Tanaka N, Yahiro C, et al
    A case of cutaneous clear cell sarcoma of the sole with an epidermal component.
    Eur J Dermatol. 2024;34:300-301.
    

    >> Share

    
    
89. ICKRATH K, Fleissner J, Egenolf T, Schmieder A, et al
    Acrodermatitis continua of Hallopeau upon PD-L1 therapy for metastatic urothelial carcinoma.
    Eur J Dermatol. 2024;34:296-298.
    

    >> Share

    
    
90. FUJII K, Yoshizaki A, Matsuoka A, Baba N, et al
    Progression of CD8-positive Sezary syndrome from mycosis fungoides following dupilumab treatment.
    Eur J Dermatol. 2024;34:294-296.
    

    >> Share

    
    
91. GONG Z, Peng S, Wang H, Jiang X, et al
    Unilateral focal palmoplantar keratoderma associated with a postzygotic variant in PIK3CA and activation of the PI3K/AKT/mTOR pathway.
    Eur J Dermatol. 2024;34:287-293.
    

    >> Share

    
    
92. YOSHIDA S, Shiraishi K, Yatsuzuka K, Kohri N, et al
    Effects of hot bath therapy on cholinergic urticaria with hypohidrosis or anhidrosis.
    Eur J Dermatol. 2024;34:271-275.
    

    >> Share

    
    
93. VERALDI S, Schianchi R, Nazzaro G
    Necrotic ulcers caused by Loxosceles rufescens bites: a report of seven patients and scanning electron microscopy of the spider.
    Eur J Dermatol. 2024;34:267-270.
    

    >> Share

    
    
94. HUANG X, Wang Q, Yan QH, Feng S, et al
    Clinico-mycological study of onychomycosis and in vitro antifungal susceptibility of Trichophyton rubrum.
    Eur J Dermatol. 2024;34:260-266.
    

    >> Share

    
    
95. ESTEBARANZ JLL, Gonzalez-Montagut CM, Gonzalez J, Miguel IAGS, et al
    Real-world evidence for vitiligo using an electronic medical records database in Spain: the REVEAL-ES study.
    Eur J Dermatol. 2024;34:251-259.
    

    >> Share

    
    

    
    Int J Cancer

96. BRANDT C, Vo JB, Gierach GL, Cheng I, et al
    Second primary cancer risks according to race and ethnicity among U.S. breast cancer survivors.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34971.
    

    >> Share

    
    
97. BARNES I, Garcia-Closas M, Gathani T, Sweetland S, et al
    A comparative analysis of risk factor associations with interval and screen-detected breast cancers: A large UK prospective study.
    Int J Cancer. 2024;155:979-987.
    

    >> Share

    
    

    
    Mycoses

98. CORTES-LOPEZ PN, Guzman-Montijo E, Fuentes-Venado CE, Arenas R, et al
    Cutaneous fusarium disease and leukaemias: A systematic review.
    Mycoses. 2024;67:e13759.
    

    >> Share

    
    

    
    N Engl J Med

99. MEROLA JF, Cochran RL, Kroshinsky D, Prabhu M, et al
    Case 22-2024: A 30-Year-Old Woman with Postpartum Fever, Abdominal Pain, and Skin Ulcers.
    N Engl J Med. 2024;391:260-271.
    

    >> Share

    
    

    
    PLoS One

100. JENKINS V, Habibi R, Hall V, Leonard P, et al
     Roll-out of an educational workshop to improve knowledge and self-confidence of healthcare professionals engaged in mainstreaming of breast cancer genetics.
     PLoS One. 2024;19:e0307301.
     

     >> Share

     
     
101. LIM JH, Jang YS, Kim DB, Jang SY, et al
     Association between body mass index and atopic dermatitis among adolescents: Findings from a national cross-sectional study in Korea.
     PLoS One. 2024;19:e0307140.
     

     >> Share

     
     
102. GEREMEW H, Golla EB, Simegn MB, Abate A, et al
     Late-stage diagnosis: The driving force behind high breast cancer mortality in Ethiopia: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0307283.
     

     >> Share

     
     
103. WANG X, Dai Z, Zhu X, Li Y, et al
     Effects of mindfulness-based stress reduction on quality of life of breast cancer patient: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0306643.
     

     >> Share

     
     
104. AFFANDI AM, Thiruchelvam K
     Patient perspective on psoriasis: Psychosocial burden of psoriasis and its management in Malaysia.
     PLoS One. 2024;19:e0305870.
     

     >> Share

     
     
105. LANG-ILLIEVICH K, Klivinyi C, Schulze-Bauer H, Elhelali A, et al
     The effect of photobiomodulation on histamine and Mucuna pruriens-induced pruritus, hyperknesis and alloknesis in healthy volunteers: A double-blind, randomized, sham-controlled study.
     PLoS One. 2024;19:e0307034.
     

     >> Share

     
     
106. PATRA A, Ali SS, Devi NM, Qadeer AS, et al
     Prevalence of BRCA mutation in breast and ovarian cancer among women in India: A systematic review and meta-analysis protocol.
     PLoS One. 2024;19:e0306612.
     

     >> Share

     
     
107. JUNG M, Nicholas N, Grindrod S, Dritschilo A, et al
     Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth.
     PLoS One. 2024;19:e0306168.
     

     >> Share

     
     

     
     Proc Natl Acad Sci U S A

108. ZIN I, China A, Khan K, Nag JK, et al
     AKT-dependent nuclear localization of EPRS1 activates PARP1 in breast cancer cells.
     Proc Natl Acad Sci U S A. 2024;121:e2303642121.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share